z-logo
open-access-imgOpen Access
Extracorporeal shock wave therapy does not improve hypertensive nephropathy
Author(s) -
Caron Jonathan,
Michel PierreAntoine,
Dussaule JeanClaude,
Chatziantoniou Christos,
Ronco Pierre,
Boffa JeanJacques
Publication year - 2016
Publication title -
physiological reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 39
ISSN - 2051-817X
DOI - 10.14814/phy2.12699
Subject(s) - medicine , urology , renal function , nephropathy , kidney , creatinine , glomerulosclerosis , angiogenesis , proteinuria , extracorporeal , endocrinology , pathology , diabetes mellitus
Low‐energy extracorporeal shock wave therapy ( SWT ) has been shown to improve myocardial dysfunction, hind limb ischemia, erectile function, and to facilitate cell therapy and healing process. These therapeutic effects were mainly due to promoting angiogenesis. Since chronic kidney diseases are characterized by renal fibrosis and capillaries rarefaction, they may benefit from a proangiogenic treatment. The objective of our study was to determine whether SWT could ameliorate renal repair and favor angiogenesis in L‐ NAME ‐induced hypertensive nephropathy in rats. SWT was started when proteinuria exceeded 1 g/mmol of creatinine and 1 week after L‐ NAME removal. SWT consisted of implying 0.09  mJ /mm 2 (400 shots), 3 times per week. After 4 weeks of SWT , blood pressure, renal function and urinary protein excretion did not differ between treated ( LN  +  SWT ) and untreated rats ( LN ). Histological lesions including glomerulosclerosis and arteriolosclerosis scores, tubular dilatation and interstitial fibrosis were similar in both groups. In addition, peritubular capillaries and eNOS , VEGF , VEGF ‐R, SDF ‐1 gene expressions did not increase in SWT ‐treated compared to untreated animals. No procedural complications or adverse effects were observed in control (C +  SWT ) and hypertensive rats ( LN  +  SWT ). These results suggest that extracorporeal kidney shock wave therapy does not induce angiogenesis and does not improve renal function and structure, at least in the model of hypertensive nephropathy although the treatment is well tolerated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here